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Augmentation of inﬂ  uenza surveillance with 
rapid antigen detection at the point-of-care: 
results of a pilot study in Tasmania, 2004
Kate S Turner,1 Kelly A Shaw,2 David J Coleman,3 Avner Misrachi4
Abstract
Tasmania contributes very few laboratory conﬁ  rmed cases to Australia’s national inﬂ  uenza surveil-
lance statistics. In 2004, a study was conducted to pilot test sentinel syndromic surveillance for inﬂ  u-
enza-like illness supplemented by point-of-care testing using the Binax Now Flu A Test Kit and by viral 
culture, to assess the feasibility and acceptability of this method of surveillance. Overall, the goal of 
such a system would be to increase laboratory surveillance activity within Tasmania and increase the 
number of specimens sent for viral culture. Five sites participated in the study, including three public 
hospital emergency departments and two general practices. Despite being conducted during a period of 
low inﬂ  uenza activity, the pilot study demonstrated that augmentation of syndromic surveillance with 
point-of-care testing is both feasible and acceptable but is best conducted in the general practice setting. 
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Introduction
Inﬂ  uenza is a highly contagious, febrile, acute respi-
ratory disease in humans. The incidence of inﬂ  uenza 
is estimated at 500 million cases annually, or one 
in every three of the world’s population per year.1 A 
deﬁ  nitive diagnosis of inﬂ  uenza requires laboratory 
conﬁ  rmation, since clinical diagnosis on the basis of 
clinical symptoms is not sensitive and the predictive 
value of clinical diagnosis of inﬂ  uenza in the absence 
of an epidemic is only 30–40 per cent.2
Diagnostic tests for inﬂ  uenza fall into four categories: 
virus isolation; detection of viral nucleic acid; detec-
tion of viral proteins; and serological diagnosis. Viral 
isolation i.e. culture, is the current gold standard for 
laboratory diagnosis. Detection of viral nucleic acid 
is widely used for typing and subtyping inﬂ  uenza 
viruses. The advantage of nucleic acid ampliﬁ  cation 
tests (NAAT) is their high sensitivity and speciﬁ  city, 
more rapid turn-around time, an expanded range of 
specimen types suitable for testing, and the ability 
to detect viruses that are difﬁ  cult to grow in cell cul-
ture.3,4 However, NAAT is not universally available 
and signiﬁ   cant time delays in centres with poor 
access to inﬂ  uenza NAAT-capable laboratories pre-
clude its clinical usefulness, reducing the number of 
tests clinicians order.
Tests that detect viral proteins at the point-of-care 
are becoming more common. They are easy to 
perform and results are available in less than an 
hour. However, they are considerably less sensitive 
than culture or NAAT.5 A positive test is useful, for 
both directing initiation of therapy in the clinician’s 
ofﬁ  ce and making a positive diagnosis of inﬂ  uenza 
in patients with inﬂ   uenza-like clinical syndromes.6 
As the technology is continuing to advance, the test 
sensitivity is likely to improve.
In Tasmania, laboratories have very limited diag-
nostic capability for inﬂ   uenza. Specimens for 
culture, serology and NAAT are all sent interstate 
for processing. This creates substantial time delays 
before results become available. As a consequence, 
testing rates by Tasmanian clinicians for inﬂ  uenza 
are very low and Tasmania contributes very few 
laboratory conﬁ   rmed cases to Australia’s national 
inﬂ  uenza surveillance statistics.202  CDI  Vol 30  No 2  2006
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Public health surveillance for inﬂ   uenza is neces-
sary to determine the distribution of illness, detect 
outbreaks, monitor changes in disease agents and 
facilitate planning.7 Increasingly, non-traditional 
methods of surveillance are being utilised. Point-of-
care testing trials for inﬂ  uenza have been conducted 
in Hawaii and Germany. These trials have dem-
onstrated that integrating inﬂ   uenza rapid antigen 
testing into public health surveillance, by coupling 
rapid tests with cultures, improves testing rates by 
clinicians (as an immediate result is provided by the 
point-of-care test) and enhances inﬂ  uenza surveil-
lance (as the culture specimen allows the reference 
centres to characterise circulating viral strains and 
to detect fully new variants).8,2
The aims of this study were to pilot test sentinel 
syndromic surveillance for inﬂ  uenza-like illness (ILI) 
in Tasmania, supplemented by point-of-care testing 
using the Binax Now Flu A Test Kit and by viral cul-
ture, to assess the feasibility and acceptability of this 
method of surveillance.
Methods
Surveillance was conducted between May and 
October 2004. The case deﬁ  nition adopted for ILI 
was: presentation with cough, fever (greater than or 
equal to 37.5 degrees Celsius) and fatigue.9
Five sites were recruited to the project. These were 
the Departments of Emergency Medicine (DEM) 
of the Royal Hobart Hospital, Launceston General 
Hospital and North West Regional Hospital, East 
Devonport Medical Centre and the After Hours 
Doctors Service at Derwent Park. The sites were 
selected to represent the geographical transport 
entry points into Tasmania. The Royal Hobart 
Hospital and After Hours Doctors Service are both 
in Hobart, in southern Tasmania. Domestic ﬂ  ights 
enter Hobart from Sydney, Brisbane and Melbourne. 
Cruise ships dock in Hobart, arriving from multiple 
international destinations. The Launceston General 
Hospital is in Launceston in northern Tasmania. 
Domestic ﬂ  ights from Sydney and Melbourne enter 
Launceston. The North West Regional Hospital is 
in Burnie in north-west Tasmania. The City Medical 
Practice is in Devonport, also in north-west Tasmania. 
East Devonport is the main entry point for domestic 
passenger ships arriving by sea into Tasmania.
A site co-ordinator was nominated for each sen-
tinel site. Staff from the Tasmanian Department 
of Health and Human Services Communicable 
Diseases Prevention Unit (DHHS-CDPU) briefed 
the coordinator on the project and requirements for 
reporting. Medical staff at each site were trained in 
the use of the Binax Now Flu A Test Kit. They were 
briefed on the case deﬁ  nition for inﬂ  uenza and the 
reporting requirements for each patient in the study. 
The information collected included: the surveillance 
period dates, the number of patients in each report-
ing period meeting the case deﬁ  nition for ILI, the sex 
and age of each case, and whether or not the case 
had been vaccinated against inﬂ  uenza in 2004.
Data were entered into an Excel spreadsheet and 
descriptive statistical analysis undertaken using 
Excel 2000. At the conclusion of the project DHHS-
CDPU staff administered purpose-designed surveys 
to each of the site coordinators, seeking information 
regarding the feasibility and acceptability of the sur-
veillance system, and the clinical utility and ease of 
use of the point-of-care test.
Results
Inﬂ  uenza-like illness (ILI)
During the surveillance period, reports were received 
from all sites as per the reporting requirements of 
the study.
From all sites there was a total of 53 patients satisfy-
ing the study criteria for the clinical diagnosis of ILI, 
as deﬁ  ned by the case deﬁ  nition above. Of these, 
40 (76%) were tested with the Binax Now Flu A Test 
Kit. No positive results for inﬂ  uenza were obtained 
using the Binax Now Flu A Test Kit and no clinical 
specimens were sent for culture.
Inﬂ  uenza vaccination status was recorded for 30 of 
the 53 cases of ILI (56%). Of these, 7 (23%) were 
recorded as having received inﬂ   uenza vaccine in 
2004.
Survey results
Survey results were received from 3 of the 5 partici-
pating sites (response rate = 60%).
Procedural aspects of the surveillance method
The written information supplied to each site was 
considered adequate for the purposes of the project 
and available public health support was sufﬁ  cient. 
Respondents indicated that the case deﬁ  nition of ILI 
was simple and easy to apply for the purposes of 
surveillance and to indicate which patients should 
receive a point-of-care test. The availability of a 
rapid test for inﬂ  uenza was regarded as an incentive 
to test patients. However, respondents did indicate 
that incentives for their involvement in surveillance 
activities would improve their participation and that 
without incentives it was unlikely they would con-
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Feasibility and acceptability of the point-of-care 
test
The majority of respondents considered the Binax 
Now Flu A Test Kit easy to use. However, the time 
taken before results could be read (15 minutes) was 
an inconvenience in both DEM and general prac-
tice settings. Within the DEM it was not feasible to 
ensure that the quality of nasal specimens collected 
by different staff members remained of a consist-
ently high quality. This was not identiﬁ  ed as an issue 
in the general practice setting.
Discussion
Inﬂ   uenza activity in Australia during 2004 was 
low. A total of 2,116 cases of laboratory-conﬁ  rmed 
inﬂ  uenza were reported via the National Inﬂ  uenza 
Surveillance Scheme, which was 41 per cent lower 
than the number of reported cases in 2003.10 In 
Tasmania, there were two notiﬁ  ed cases of labora-
tory-conﬁ  rmed inﬂ  uenza A and one case of labora-
tory-conﬁ  rmed  inﬂ   uenza B during 2004. However, 
because ILI was present, pilot testing of sentinel 
surveillance could still be undertaken. In general, 
participants viewed the surveillance system favour-
ably as an appropriate method of inﬂ  uenza surveil-
lance in Tasmania.
There were multiple barriers to conducting surveil-
lance for inﬂ  uenza in the DEM setting. It was not 
possible to ensure that all staff-members were 
identifying and recording patients who met the case 
deﬁ  nition of ILI or that testing for inﬂ  uenza A of all 
patients who met the case deﬁ  nition was occurring. 
Additionally, it was not possible to identify whether 
the staff-members using the Binax Now Flu A Test 
Kit were using the test or taking nasopharyngeal 
samples appropriately. It was felt that staff did not 
have the time to undertake sufﬁ  cient education or 
training to ensure that the testing protocol was reli-
able between users. After the sample was acquired, 
it took 15 minutes before the result could be read. In 
a busy emergency department, this was seen as a 
barrier to the test’s use. Staff did identify that lack of 
remuneration was a barrier for undertaking surveil-
lance activities.
Surveillance in general practice was more accept-
able and feasible. Staff could be appropriately 
trained and educated on the use of the test in this 
setting. The time taken before the result could be 
read was seen as only a small additional time bur-
den. Case ascertainment was more complete and 
the protocols for the study were more rigorously 
applied. However, general practitioners also identi-
ﬁ  ed that the lack of remuneration for their participa-
tion was a barrier – particularly as the presence or 
absence of inﬂ  uenza did not necessarily alter their 
patient management.
Workforce capacity within the DHHS-CDPU was 
also an issue identiﬁ  ed in this study. Frequent and 
regular communication with sentinel sites was 
necessary to ensure compliance with data reporting 
requirements. Data collection and analysis were also 
labour intensive. The workforce requirements within 
the DHHS-CDPU were signiﬁ  cantly underestimated 
and future surveillance using this method will need 
to address this.
There are signiﬁ  cant limitations with the point-of-care 
test itself. The sensitivity of the point-of-care test is 
only 65–77 per cent compared with culture or NAAT 
testing for known circulating inﬂ   uenza strains and 
is probably much lower for pandemic strains (point-
of-care tests are unlikely to detect pandemic strains 
of inﬂ  uenza). However, in spite of this, clinical trials 
have demonstrated that a positive test is clinically 
useful and by coupling the point-of-care test with viral 
culture, a sufﬁ  ciently sensitive test is utilised that is 
capable of detecting pandemic strains.6 Many viruses 
cause ILI in patients and are not generally distin-
guishable from inﬂ  uenza on clinical grounds alone. 
These include respiratory syncytial virus, rhinovirus, 
human corona viruses, human metapneumovirus, 
adenovirus, picornavirus and parainﬂ  uenza  virus.3 
Antigen detection is not useful for differentiating 
between these viruses.
The pilot study demonstrated that augmentation of 
syndromic surveillance with point-of-care testing is 
both feasible and acceptable. However, the setting 
in which this form of surveillance is best conducted is 
general practice. The procedural barriers within the 
DEM setting were far greater and the model can be 
more efﬁ  ciently applied within the general practice 
setting, without sacriﬁ  cing breadth of surveillance.
To adopt this form of surveillance within Tasmania, 
selected general practitioners could be targeted. 
Financial remuneration for service providers would 
almost certainly be necessary. Teams at each par-
ticipating general practice (including practice nurses, 
practice managers and general practitioners) could 
be formed to conduct sentinel surveillance. This 
would ensure that continuity of surveillance is main-
tained and would improve data collection, timely 
reporting and minimise the time burden on the 
general practitioner by efﬁ   ciently utilising practice 
support staff.
It is also foreseeable that this method of surveil-
lance could be conducted by health personnel via 
Community Assessment and Information Centres 
that would become operational in the Tasmanian 
response to a pandemic inﬂ  uenza threat.
Overall, the goal of such a system would be to increase 
laboratory surveillance activity within Tasmania and 
increase the number of specimens sent for viral cul-204  CDI  Vol 30  No 2  2006
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ture. This would establish an improved and enhanced 
method of inﬂ  uenza surveillance in Tasmania, which 
is an important inter-pandemic priority.
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